01 Jan 2021

Future Unicorn Award nominee: Oncompass Medicine

Future Unicorn Award 2021

Oncompass Medicine is an AI-based medical software used to choose the right targeted cancer therapy for every patient.

Oncompass Medicine provide online software as a service decision support to oncologists to choose the right targeted therapy for their patients. With AI, they can compute more than 20,000 potential associations between cancer genes and targeted therapies in 20 milliseconds to predict each patient’s response to targeted therapies. It increases cancer patients’ chance to receive the right effective treatment, lower unnecessary costs and help pharma companies develop therapies faster and safer.

Learn more about Oncompass Medicine

What will you do if you win the Future Unicorn Award?

“If we win the Future Unicorn Award, we will reach out to IT companies and other digital health companies to develop our tool and combine the best digital solutions for cancer patients. We will also reach out to policymakers to accelerate the implementation of new technologies in European countries’ clinical practice.”

Oncompass Medicine

To learn more about Oncompass Medicine, visit their website

About the Future Unicorn Award

  • The Future Unicorn Award aims to highlight innovative start-ups and scale-ups that have the potential to become Europe’s next unicorns. The award is compiled by asking all the national trade associations affiliated with DIGITALEUROPE to nominate a single SME from their country. This results in a truly pan-European selection of incredible digital companies from all sectors.

    The award will be delivered at our flagship event, Masters of Digital on 4 February.

Publication & Brochure 03 Feb 2021
Scaling in Europe
Press Release 06 Feb 2020
Artificial intelligence scale-up Corti wins Future Unicorn Award
Press Release 21 Feb 2019
DIGITALEUROPE Unicorn Award 2019 “Here are Europe’s future digital champions!”
Hit enter to search or ESC to close
This website uses cookies
We use cookies and similar techonologies to adjust your preferences, analyze traffic and measure the effectiveness of campaigns. You consent to the use of our cookies by continuing to browse this website.
Decline
Accept